Rockville biotech RegenxBio launches clinical trial in muscular dystrophy


It's one of a series of treatments the company is developing as it aims to bring multiple products to market by 2025.

Previous RTP drugmaker Fennec sues Cipla over generics effort
Next Hip Hop Sweet Shop plans to return to as a food truck in March